About Biogenity

Biogenity was founded in 2018 to provide high-quality omics research. Early on we learned that researchers needed more than just data generation – they needed expert guidance to design studies, select panels, and interpret results. Since then, we have partnered with hundreds of researchers worldwide to deliver tailored omics solutions that drive biological insights.

Located in Aalborg, Denmark, our team of omics specialists collaborates closely with clients to align analytical strategies with research goals.

Get Biogenity's latest news

We are hiring an Omics Scientist/Customer Consultant

August 7, 2025 | Louis Loeb

We are seeking a new colleague to join us in supporting scientists from various industries, including pharmaceutical, biotech, food technology, and academia, in their omics research projects. We are looking for a highly skilled and motivated individual with a passion for Omics and customer consulting. The role requires you have experience within at least one of following areas: transcriptomics, metabolomes or proteomics. This includes knowledge of sample requirements, different approaches to sample analysis, and hands-on experience with data interpretation and analysis. You also need to be experienced R user, as the work include execution, optimization and development of analytical pipelines in R or python.

Read the job advert More news

Other R&D developments

Mapping exposure-induced immune effects

Biogenity is part of EXPOSIM, an EU project that investigates environmental stressors as causal determinants for immune-mediated diseases. The project maps and prioritises evidence on how environmental stressors affect immune health, creating a strong evidence base for knowledge-based policy-making. Our role focuses on developing neural networks to identify potential causal links between exposures and immune-related diseases using the DOC#X database.

Biogenity also contributed to the recently concluded EXIMIOUS project, which pioneered new ways of assessing the human exposome and its association with immune-mediated diseases. EXPOSIM builds directly on EXIMIOUS, and we continue this work by carrying forward the methods and insights we helped develop into EXPOSIM.

Horizon Europe projects

EXIMIOUS & EXPOSIM

Our trusted partners

Plant a tree with Biogenity

Biogenity donates a dozen trees for every project delivered to support local communities, reforestation, and reduce CO₂ emissions. See how we are making a difference together.